Laddar...
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
Vandetanib (ZD6474) is an orally bioavailable small molecule tyrosine kinase inhibitor of multiple growth factor receptors, including RET (Rearrange during transfection), vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor receptor (EGFR). The activity against RET and...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Libertas Academica
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3153121/ https://ncbi.nlm.nih.gov/pubmed/21836817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S6197 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|